The microbiota modulates gut physiology and behavioral abnormalities associated with autism
By E. Hsiao, S. Mcbride, S. Hsien, G. Sharon, Embriette R. Hyde, Tyler McCue, Julian A. Codelli, J. Chow, S. Reisman, J. Petrosino and 2 more. Cell, 2013
3,012 citations recorded by the source corpus.
SUMMARY Although autism spectrum disorder (ASD) is defined by core behavioral impairments, gastrointestinal (GI) symptoms are commonly reported. Subsets of ASD individuals display dysbiosis of the gut microbiota, and some exhibit increased intestinal permeability. Here we demonstrate GI barrier defects and microbiota alterations in a mouse model displaying features of ASD, maternal immune activation (MIA). Oral treatment of MIA offspring with the human commensal Bacteroides fragilis corrects gut permeability, alters microbial composition and ameliorates ASD-related defects in communicative, stereotypic, anxiety-like and sensorimotor behaviors. MIA offspring display an altered serum metabolomic profile, and B. fragilis modulates levels of several metabolites. Treating naïve mice with a metabolite that is increased by MIA and restored by B. fragilis causes behavioral abnormalities, suggesting that gut bacterial effects on the host metabolome impact behavior. Taken together, these findings support a gut-microbiome-brain connection in ASD and identify a potential probiotic therapy for GI and behavioral symptoms of autism.
Subfields: Biological Psychiatry, Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/ad3879a1033cf045f0dccf942134a4c1a864a639
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biological Psychiatry
In Molecular Biology
In Physiology
Citations in the corpus
- The role of microbiome in central nervous system disorders (2013, neutral): “fragilis could correct behavioral abnormalities and metabolomic profile typified in ASD and ameliorate ASD-relevant GI barrier deficits in mice (de Theije et al., 2013; Hsiao et al., 2013).”
- The maternal interleukin-17a pathway in mice promotes autismlike phenotypes in offspring (2016, background): “Some studies have reported reduced USV calls upon MIA (8, 31), but these opposite effects may reflect differences in methodological approaches, including dose and number of exposures to poly(I:C) as well as timing of poly(I:C) administration.”
- The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation (2016, background): “Dysbiosis of the microbiome has been associated with a large number of health problems and causally implicated in metabolic, immunological, and developmental disorders, as well as susceptibility to development of infectious diseases [4–11].”
- The treatment-naive microbiome in new-onset Crohn's disease. (2014, background): “, 2013), autism (Hsiao et al., 2013), or IBD (Papa et al.”
- The gut microbiome: Relationships with disease and opportunities for therapy (2018, background): “fragilis Restores the integrity of the intestinal barrier and ameliorates autistic-like behavior (Hsiao et al., 2013)”
- Microbiota in health and diseases (2022, background): “In GF rats, increased levels of neurotransmitters such as norepinephrine, dopamine, and serotonin were reported in the striatum, whereas dopaminergic turnover was found to be decreased in the frontal cortex, striatum, and hippocampus of GF rats.262 Few other study findings using GF mice models have ”
- Stress & the gut-brain axis: Regulation by the microbiome (2017, neutral): “Intriguingly, it has become increasingly clear that b cteria are required for normal brain development [25-27, 29, 32, 33] as well as brain fu nction in adulthood.”
- The ecology of the microbiome: Networks, competition, and stability (2015, background): “(13) Combining this with equations (12) and (13) in (10) and (11) allows us to determine the coordinates of our eigenvalue ellipse.”
- Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice. (2017, neutral): “Previous studies have shown that Bacteroides fragilis could reverse autism-like behaviors in mice (49).”